Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Trump orders changes to Medicare drug price negotiations

President Donald Trump has directed the Department of Health and Human Services to work with Congress on changes to Medicare drug price negotiations, with the stated goal of further lowering prescription costs.

WiSE CRT system EBR Systems leadless pacing

FDA approves leadless CRT device for heart failure

The WiSE CRT system is approximately the size of a single cooked grain of rice. It works with a patient’s existing implant to provide biventricular pacing. 

HeartFocus DESKi

FDA clears AI-powered echocardiography software

HeartFocus guides users through the entire process, making it so that even novices can deliver high-quality echocardiograms every time.

Thumbnail

American College of Radiology criticizes prominent study claiming CT imaging causes cancer

“These estimates put CT scanning on par with other well-known risk factors for cancer, including alcohol and obesity," experts write in JAMA Internal Medicine

Edwards Lifesciences Sapien M3

Edwards Lifesciences announces key approval for new mitral valve replacement system

The Sapien M3 device was designed to treat symptomatic mitral regurgitation in patients who are not suitable candidates for surgery or transcatheter edge-to-edge repair.

SCAI President James B. Hermiller, Jr., MD, director of the transcatheter structural heart program at Ascension St. Vincent Heart Center, Indianapolis, outlined the organization’s key policy priorities for the year. Among them: physician payment reform, peer review overhaul, medical education debt relief, the elimination of non-compete clauses, and physician mental health protections.

Reimbursements, non-compete clauses and more: SCAI focused on key policies in interventional cardiology

SCAI President James B. Hermiller, Jr., MD, detailed the group's key policy concerns in 2025 and beyond in a new video interview. 

Thumbnail

FDA takes first step toward ending animal testing as part of ‘3.0 modernization'

Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.

Kit Crancer, Radiology Business Management Association (RBMA) Board member, senior vice president of radiology and public policy at Rayus, offers an update on where Medicare reform is at in Congress and how medical societies may be able to get more traction in state legislatures. #RBMA

States may be a better bet for radiology advocacy than Washington

RBMA board member Kit Crancer offers an update on Medicare reform and advocacy in Congress and how medical societies may be able to get more traction in state legislatures.